Collectively, these results show that the two CPE-upregulating agomirs could exert protective effects in the hippocampus of APP/PS1 mice at multiple levels, suggesting that the agomir-induced boosting neurogenesis reduces the appearance of several AD hallmarks, thus influencing AD neuropathologies. The gene discussed is APP; the disease is Alzheimer disease.